Пилотное исследование острой токсичности ингибитора TDP1; Перспективы развития фундаментальных наук; Т. 4 : Биология и фундаментальная медицина
| Parent link: | Перспективы развития фундаментальных наук=Prospects of Fundamental Sciences Development: сборник научных трудов XV Международной конференции студентов, аспирантов и молодых ученых, г. Томск, 24-27 апреля 2018 г./ Национальный исследовательский Томский политехнический университет (ТПУ) ; под ред. И. А. Курзиной, Г. А. Вороновой.— , 2018 Т. 4 : Биология и фундаментальная медицина.— 2018.— [С. 63-65] |
|---|---|
| Hlavní autor: | |
| Korporativní autor: | |
| Další autoři: | , |
| Shrnutí: | Заглавие с экрана To date, malignant neoplasms are the most pressing medical and social problem both in our country and abroad, despite the introduction of innovative technologies in diagnostics, therapy, and prophylactics. Lung cancer is the most common malignant neoplasm worldwide. Since the beginning of the twentieth century, the incidence of lung cancer has increased, and its growth is especially pronounced in industrially developed countries, where it ranks first in the structure of cancer morbidity. In Russia, over the last ten years, the incidence of lung cancer has decreased, but yet more than 1000000 new cases are diagnosed annually, and lung cancer by remains in first place among all malignant neoplasms among men. Tyrosyl-DNA Phosphodiesterase 1 (Tdp1) that result in stalled Top1 are commonly employed against cancer. Nowadays, major methods are used for the treatment of patients with lung cancer: surgery, radiation, chemoradiation, drugs, and combined methods. Combination chemotherapy with DNA repair inhibitors can potentially improve response to these widely used chemotherapeutics. |
| Jazyk: | ruština |
| Vydáno: |
2018
|
| Témata: | |
| On-line přístup: | http://earchive.tpu.ru/handle/11683/50883 |
| Médium: | Elektronický zdroj Kapitola |
| KOHA link: | https://koha.lib.tpu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=627650 |
MARC
| LEADER | 00000naa2a2200000 4500 | ||
|---|---|---|---|
| 001 | 627650 | ||
| 005 | 20231101133454.0 | ||
| 035 | |a (RuTPU)RU\TPU\conf\27595 | ||
| 035 | |a RU\TPU\conf\27594 | ||
| 090 | |a 627650 | ||
| 100 | |a 20180918d2018 k y0rusy50 ca | ||
| 101 | 0 | |a rus |d eng | |
| 102 | |a RU | ||
| 105 | |a y z 100zy | ||
| 135 | |a drgn ---uucaa | ||
| 181 | 0 | |a i | |
| 182 | 0 | |a b | |
| 200 | 1 | |a Пилотное исследование острой токсичности ингибитора TDP1 |d Pilot study of acute toxicity of TDP1 inhibitor |f Е. О. Казакова |g науч. конс. А. А. Бакибаев, В. В. Быков | |
| 203 | |a Текст |c электронный | ||
| 230 | |a 1 компьютерный файл (pdf; 181 Kb) | ||
| 300 | |a Заглавие с экрана | ||
| 320 | |a [Библиогр.: с. 65 (4 назв.)] | ||
| 330 | |a To date, malignant neoplasms are the most pressing medical and social problem both in our country and abroad, despite the introduction of innovative technologies in diagnostics, therapy, and prophylactics. Lung cancer is the most common malignant neoplasm worldwide. Since the beginning of the twentieth century, the incidence of lung cancer has increased, and its growth is especially pronounced in industrially developed countries, where it ranks first in the structure of cancer morbidity. In Russia, over the last ten years, the incidence of lung cancer has decreased, but yet more than 1000000 new cases are diagnosed annually, and lung cancer by remains in first place among all malignant neoplasms among men. Tyrosyl-DNA Phosphodiesterase 1 (Tdp1) that result in stalled Top1 are commonly employed against cancer. Nowadays, major methods are used for the treatment of patients with lung cancer: surgery, radiation, chemoradiation, drugs, and combined methods. Combination chemotherapy with DNA repair inhibitors can potentially improve response to these widely used chemotherapeutics. | ||
| 461 | 1 | |0 (RuTPU)RU\TPU\conf\26928 |t Перспективы развития фундаментальных наук |l Prospects of Fundamental Sciences Development |o сборник научных трудов XV Международной конференции студентов, аспирантов и молодых ученых, г. Томск, 24-27 апреля 2018 г. |o в 7 т. |f Национальный исследовательский Томский политехнический университет (ТПУ) ; под ред. И. А. Курзиной, Г. А. Вороновой |d 2018 | |
| 463 | 1 | |0 (RuTPU)RU\TPU\conf\26932 |t Т. 4 : Биология и фундаментальная медицина |v [С. 63-65] |d 2018 | |
| 510 | 1 | |a Pilot study of acute toxicity of TDP1 inhibitor |z eng | |
| 610 | 1 | |a электронный ресурс | |
| 610 | 1 | |a токсичность | |
| 610 | 1 | |a злокачественные новообразования | |
| 610 | 1 | |a диагностика | |
| 610 | 1 | |a профилактика | |
| 610 | 1 | |a инновационные технологии | |
| 700 | 1 | |a Казакова |b Е. О. | |
| 702 | 1 | |a Бакибаев |b А. А. |4 695 | |
| 702 | 1 | |a Быков |b В. В. |4 727 | |
| 712 | 0 | 2 | |a Национальный исследовательский Томский государственный университет (ТГУ) |c (2009- ) |2 stltpush |3 (RuTPU)RU\TPU\col\17230 |
| 801 | 2 | |a RU |b 63413507 |c 20181008 |g RCR | |
| 856 | 4 | |u http://earchive.tpu.ru/handle/11683/50883 | |
| 942 | |c BK | ||